Home > Insider Trading > Filing (0001209191-15-048105)

Filing Details

Accession Number:: 0001209191-15-048105
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-05-29 19:57:23
Reporting Period:: 2015-05-27

Filing Date:: 2015-05-29
Accepted Time:: 2015-05-29 19:57:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1584509	Aramark	ARMK	Retail-Eating Places (5812)	208236097

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
929408	Warburg Pincus & Co.	450 Lexington Avenue New York NY 10017	No	No	Yes	No
1162870	Warburg Pincus Llc	450 Lexington Avenue New York NY 10017	No	No	Yes	No
1220638	P. Joseph Landy	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1239318	R Charles Kaye	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1332737	Warburg Pincus Private Equity Ix, L.p.	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1621224	Warburg Pincus Partners Gp Llc	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1621242	Warburg Pincus Partners, L.p.	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1621874	Wpp Gp Llc	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1622527	L.p. Gp Ix Pincus Warburg	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.01 Per Share ("Common Stock")	Disposition	2015-05-27	7,500,000	$31.47	6,517,070	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents shares of common stock, par value $0.01 per share ("Common Stock") of Aramark (the "Issuer"). Warburg Pincus Private Equity IX, L.P., a Delaware limited partnership ("WP IX") is the direct record owner of the securities reported herein. Warburg Pincus IX GP L.P., a Delaware limited partnership ("WP IX GP LP"), is the general partner of WP IX. WPP GP LLC, a Delaware limited liability company ("WPP GP LLC"), is the general partner of WP IX GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP LLC. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP LLC"), is the general partner of WP Partners.
(Continued from Footnote 1) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP LLC. Warburg Pincus LLC, a New York limited liability company ("WP LLC"), manages WP IX. Charles R. Kaye and Joseph P. Landy are each a Managing General Partner of WP and Co-Chief Executive Officers and Managing Members of WP LLC and may be deemed to control the Warburg Pincus Reporting Persons (as defined below).Each of Messrs. Kaye and Landy, together with WP IX, WP IX GP LP, WPP GP LLC, WP Partners, WP Partners GP LLC, WP and WP LLC are collectively referred to herein as the "Warburg Pincus Reporting Persons."
Each Warburg Pincus Reporting Person disclaims beneficial ownership with respect to any shares of Common Stock of the Issuer, except to the extent of its pecuniary interest in such shares of Common Stock. Solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, WP IX, WP IX GP LP, WPP GP LLC, WP Partners, WP Partners GP LLC and WP may be deemed directors-by-deputization. Information with respect to each of the Warburg Pincus Reporting Persons is given solely by such Warburg Pincus Reporting Person, and no Warburg Pincus Reporting Person has responsibility for the accuracy or completeness of information supplied by another Warburg Pincus Reporting Person.
This amount represents the $31.47 purchase price per share of Common Stock of the Issuer pursuant to that certain Underwriting Agreement, dated as of May 21, 2015, by and among the Issuer, the underwriter identified therein, WP IX and the other selling stockholders identified therein.